This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanda, T.
Right arrow Articles by Ray, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanda, T.
Right arrow Articles by Ray, R. B.

 Previous Article  |  Next Article 

Journal of Virology, January 2007, p. 669-676, Vol. 81, No. 2
0022-538X/07/$08.00+0     doi:10.1128/JVI.01496-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Small Interfering RNA Targeted to Hepatitis C Virus 5' Nontranslated Region Exerts Potent Antiviral Effect{triangledown}

Tatsuo Kanda,1 Robert Steele,1 Ranjit Ray,2,3 and Ratna B. Ray1,2,3*

Departments of Pathology,1 Internal Medicine,2 Liver Center,Saint Louis University, St. Louis, Missouri 631103

Received 13 July 2006/ Accepted 20 October 2006

Hepatitis C virus (HCV) is a major cause of cirrhosis and hepatocellular carcinoma. Interferon alone or together with ribavirin is the only therapy for HCV infection; however, a significant number of HCV-infected individuals do not respond to this treatment. Therefore, the development of new therapeutic options against HCV is a matter of urgency. In the present study, we have examined vectors carrying short hairpin RNA (shRNA) targeting the 5' nontranslated conserved region of the HCV genome for inhibition of virus replication. Initially, three sequences were selected, and all three shRNAs (psh-53, psh-274, and psh-375) suppressed HCV internal ribosome entry site (IRES)-mediated translation to different degrees in Huh-7 cells. Next, we introduced siRNA into Huh-7.5 cells persistently infected with HCV genotype 2a (JFH1). The most efficient inhibition of JFH1 replication was observed with psh-274, targeted to the portion from subdomain IIId to IIIe of the IRES. Subsequently, Huh-7.5 cells stably expressing psh-274 further displayed a significant reduction in HCV JFH1 replication. The effect of psh-274 on cell-culture-grown HCV genotype 1a (H77) was also evaluated, and inhibition of virus replication and infectivity titers was observed. In the absence of a cell-culture-grown HCV genotype 1b, the effects of psh-274 on subgenomic and full-length replicons were examined, and efficient inhibition of genome replication was observed. Therefore, we have identified a conserved sequence targeted to the HCV genome that can inhibit replication of different genotypes, suggesting the potential of siRNA as an additional therapeutic modality against HCV infection.

* Corresponding author. Mailing address: 1402 S. Grand Blvd., St. Louis, MO 63104. Phone: (314) 577-8331. Fax: (314) 771-3816. E-mail: rayrb{at}slu.edu.

{triangledown} Published ahead of print on 1 November 2006.

Journal of Virology, January 2007, p. 669-676, Vol. 81, No. 2
0022-538X/07/$08.00+0     doi:10.1128/JVI.01496-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Subramanian, N., Mani, P., Roy, S., Gnanasundram, S. V., Sarkar, D. P., Das, S. (2009). Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes. J. Gen. Virol. 90: 1812-1819 [Abstract] [Full Text]  
  • Wang, Y., Mao, S., Li, B., Tan, P., Feng, D., Wen, J. (2009). Treatment of hepatitis C virus core-positive hepatocytes with the transfer of recombinant caspase-3 using the 2',5'-oligoadenylate synthetase gene promoter. Acta Biochim Biophys Sin 41: 554-560 [Abstract] [Full Text]  
  • Pawlotsky, J.-M. (2009). Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs. Therapeutic Advances in Gastroenterology 2: 205-219 [Abstract]  
  • Kanda, T., Steele, R., Ray, R., Ray, R. B. (2007). Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes. J. Virol. 81: 12375-12381 [Abstract] [Full Text]  
  • Basu, A., Kanda, T., Beyene, A., Saito, K., Meyer, K., Ray, R. (2007). Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells. J. Virol. 81: 3933-3941 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»